Daniel Hunt

Director/Board Member at Antion Biosciences SA

Consumer Services

Health Technology

Profile

Daniel Hunt is currently a Director at Antion Biosciences SA. He completed his undergraduate degree at Stanford University and his graduate degree at the London School of Economics & Political Science.

Daniel Hunt active positions

Companies	Position	Start
Antion Biosciences SA Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini.	Director/Board Member	-

All active positions of Daniel Hunt

Training of Daniel Hunt

Stanford University	Undergraduate Degree
London School of Economics & Political Science	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Hunt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Antion Biosciences SA Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini.	Health Technology